Bahrain vs North Macedonia: Share of E. coli infections resistant to cephalosporins
Bahrain
63.0%
in 2022
North Macedonia
60.0%
in 2022
Bahrain rank
9th
North Macedonia rank
11th
Share of E. coli infections resistant to cephalosporins over time
- Bahrain
- North Macedonia
How they compare
Bahrain currently reports 63.0% against 60.0% in North Macedonia, a difference of 3.0%.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was North Macedonia ahead.
Bahrain ranks 9th and North Macedonia ranks 11th of 46 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.0% | 71.5% | 22.5% | North Macedonia |
| 2020s | 59.9% | 65.6% | 5.7% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Bahrain or North Macedonia?
- Bahrain, at 63.0% against 60.0% in North Macedonia as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Bahrain and North Macedonia?
- 3.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and North Macedonia?
- 6 years are reported by both, from 2017 to 2022.
- How do Bahrain and North Macedonia rank globally for share of e. coli infections resistant to cephalosporins?
- Bahrain ranks 9th and North Macedonia ranks 11th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).